JC
Jaimin Chandrakantbhai Patel
About Jaimin Chandrakantbhai Patel
Data last updated:
Jaimin Chandrakantbhai Patel is a Director at Ryt Life Sciences Private Limited (since 2021) and Designated Partner at Innate Technologies Llp (since 2022). The companies operate in Research & Development and Aviation. The largest current company by reported revenue is Ryt Life Sciences Private Limited at ₹74.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ryt Life Sciences Private Limited U73100GJ2021PTC126135 | Director | 05 Oct 2021 | 2021 | ₹74.5 Lakh (FY 2025) | Active |
| Innate Technologies Llp ABB-5941 | Designated Partner | 05 Jul 2022 | 2022 | Active |
Board colleagues of Jaimin Chandrakantbhai Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mangilal Jain | 09347055 | Ryt Life Sciences Private Limited | Director |
| Yadvendra Singh | 09347054 | Ryt Life Sciences Private Limited | Director |
| Jimmy Rajendrakumar Darji | 09362981 | Innate Technologies Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jaimin Chandrakantbhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaimin Chandrakantbhai Patel
Jaimin Chandrakantbhai Patel currently holds 2 directorships: Ryt Life Sciences Private Limited (Director, since 05 Oct 2021, revenue ₹74.5 Lakh (FY 2025)); Innate Technologies Llp (Designated Partner, since 05 Jul 2022).
Jaimin Chandrakantbhai Patel was first appointed on 05 Oct 2021 as Director at Ryt Life Sciences Private Limited. The most recent appointment on record is 05 Jul 2022 at Innate Technologies Llp.
The current boards of Jaimin Chandrakantbhai Patel's companies include Mangilal Jain (Ryt Life Sciences Private Limited), Yadvendra Singh (Ryt Life Sciences Private Limited), Jimmy Rajendrakumar Darji (Innate Technologies Llp).